When was LightDeck Diagnostics founded?

LightDeck Diagnostics was founded in 2009 and raised its 1st funding round within a year of its incorporation.

Where is LightDeck Diagnostics located?

LightDeck Diagnostics is headquartered in Boulder, United States. It is registered at 5603 Arapahoe Ave Ste 1, Boulder, CO 80303, US.

Who is the current CEO of LightDeck Diagnostics?

Nick Traggis of LightDeck Diagnostics.

How many employees does LightDeck Diagnostics have?

As of Jul 01, 2024, the latest employee count at LightDeck Diagnostics is 84.

Is LightDeck Diagnostics a funded company?

LightDeck Diagnostics is a funded company, having raised a total of $57M across 17 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Aug 20, 2009.

How much is LightDeck Diagnostics worth?

The last known valuation of LightDeck Diagnostics was $***** as of Sep 12, 2022.

When was the latest funding round of LightDeck Diagnostics?

LightDeck Diagnostics' latest funding was a $***** Grant (prize money) round on Jun 14, 2022, with participation from 1 investor. Its primary sector is Diversified Diagnostics. In United States, the Diversified Diagnostics sector has seen $16.5M in funding in 2026 to date.

Where does LightDeck Diagnostics rank among its competitors?

LightDeck Diagnostics ranks 4th amongst 156 active competitors, of which 24 are funded. It stands 2nd in terms of total funding among its competitors. The most recent competitor to raise funding was Achira, which secured $3.11M in May, 2024.

Who are the top competitors of LightDeck Diagnostics?

LightDeck Diagnostics' top competitors include EKF, Attomarker and Achira. Among them, Achira secured the most recent funding round in May, 2024.

LightDeck Diagnostics - 2026 Company Profile, Team, Funding & Competitors

Q: Is LightDeck Diagnostics an acquired company?

LightDeck Diagnostics got acquired by Heska on Sep 12, 2022.

LightDeck Diagnostics is an acquired company based in Boulder (United States), founded in 2009. It operates as a Developer of point-of-care diagnostic device for multiplex assays. LightDeck Diagnostics has raised $57M in funding from investors like Boulder Ventures, DARPA and Incubic, with last known valuation of $*****. The company has 156 active competitors, including 24 funded and 17 that have exited. Its top competitors include companies like EKF, Attomarker and Achira.

Company Details

Developer of point-of-care diagnostic device for multiplex assays. The company's proprietary LightDeck platform combines an advanced laser waveguide with novel materials and manufacturing techniques to deliver a portfolio of in vitro diagnostic panels. Its flagship product is the MBio Array System that uses disposable cartridges to allow fluorescence immunoassays to be run automatically and simultaneously.

Website: lightdeckdx.com
Email ID: *****@lightdeckdx.com
Phone Number: +1 **********
Registered Address: 5603 Arapahoe Ave Ste 1, Boulder, CO 80303, US

Key Metrics

Founded Year

2009

Location

Boulder, United States

Stage

Acquired

Total Funding

$57M in 17 rounds

Latest Funding Round

Grant (prize money), Jun 14, 2022, $*****

Last Known Valuation

$***** as on Sep 12, 2022

Investors

Boulder Ventures & 9 more

Ranked

4^th among 156 active competitors

Employee Count

84 as on Jul 01, 2024

Similar Companies

EKF & 162 more

Exit Details

Acquired by Heska (Sep 12, 2022)

View LightDeck Diagnostics' full profile

LightDeck Diagnostics is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
mBio Diagnostics, Inc. CIN: 20091616823 , United States, Active	Nov 24, 2009	$1M - $5M (As on Sep 05, 2012)	-	-
Mbio Diagnostics, Inc. CIN: 32077878208 , United States, Deadpooled	Feb 18, 2021	-	-	-

LightDeck Diagnostics got acquired by Heska on Sep 12, 2022 at an acquisition amount of $*****.

Click here to take a look at LightDeck Diagnostics's acquisition in detail

LightDeck Diagnostics has raised a total funding of $57M over 17 rounds. Its first funding round was on Aug 20, 2009. Its latest funding round was a Grant (prize money) round on Jun 14, 2022 for $*****. 1 investor participated in its latest round. LightDeck Diagnostics has 10 institutional investors.

Here is the list of recent funding rounds of LightDeck Diagnostics:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jun 14, 2022	6886795	Grant (prize money)	2888333	9793666	3714574	8029689
Mar 03, 2022	9368664	Series B	5729307	1350813	2678796	2039044
Mar 22, 2021	7472775	Series B	1495040	1580227	2945703	7869816

Access funding benchmarks and valuations. Sign up today!

View details of LightDeck Diagnostics's funding rounds and investors

LightDeck Diagnostics' employee count trend

LightDeck Diagnostics has 84 employees as of Jul 24. Here is LightDeck Diagnostics's employee count trend over the years:

Employee count trend for LightDeck Diagnostics

Uncover LightDeck Diagnostics' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of LightDeck Diagnostics include EKF, Attomarker and Achira. Here is the list of Top 10 competitors of LightDeck Diagnostics, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	EKF 1990, Penarth (United Kingdom), Public	Develops point-of-care and laboratory blood analyzers	$179K	Octopus Investments, IBG Beteiligungsgesellschaft Sachsen-Anhalt ... & 2 others	56/100
2nd	Attomarker 2008, Exeter (United Kingdom), Seed	Provider of at-home Covid diagnostic testing services	-	Innova Medical Group, EIC Fund & 5 others	51/100
3rd	Achira 2009, Bengaluru (India), Series B	Provider of diagnostic medical devices for screening Covid 19	$13.1M	Cipla, Catamaran & 14 others	49/100
4th	LightDeck Diagnostics 2009, Boulder (United States), Acquired	Developer of point-of-care diagnostic device for multiplex assays	$57M	Entrada Ventures, Incubic & 8 others	48/100
5th	SpinChip 2012, Oslo (Norway), Acquired	R&D company focused on manufacturing in-vitro diagnostic test cartridge	$23.4M	Kistefos, Investinor	47/100
6th	LumiraDx 2014, Waltham (United States), Acquired	Cloud based diagnostics platform for point of care diagnosing	$704M	CYwP Funds, Petrichor & 10 others	46/100
7th	Abaxis 1989, California City (United States), Acquired	Diagnostics company offering a comprehensive line of on-site diagnostic instruments and rapid tests	-	NeoMed, MedVenture Associates & 1 others	44/100
8th	EDX Medical Group 2022, Cambridge (United Kingdom), Seed	Research laboratory focused on medical diagnostics solutions	$2.15M	Tsangs Group, Bridgemere & 2 others	44/100
9th	Cygnus Technologies 2003, Southport (United States), Acquired	Manufacturer of analytical products for life science	-	-	44/100
10th	ProciseDx 2018, San Diego (United States), Acquired	Provider of a point-of-care clinical diagnosis device for healthcare professionals	$22M	Nestlé Health Science, Biosynex & 1 others	43/100